Acting on the lessons of SARS: What remains to be done?

Biosecurity and Bioterrorism

Volumn 9, Issue 2, 2011, Pages 169-174

  Toner, Eric S ^a   Nuzzo, Jennifer B ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; COMMUNICABLE DISEASE; CROSS INFECTION; DISEASE TRANSMISSION; EPIDEMIC; HUMAN; INFECTION CONTROL; METHODOLOGY; NOTE; SEVERE ACUTE RESPIRATORY SYNDROME; ZOONOSIS;

ANIMALS; COMMUNICABLE DISEASES, EMERGING; CROSS INFECTION; DISEASE OUTBREAKS; HUMANS; INFECTION CONTROL; SEVERE ACUTE RESPIRATORY SYNDROME; ZOONOSES;

EID: 79957678107     PISSN: 15387135     EISSN: None     Source Type: Journal    
DOI: 10.1089/bsp.2010.0074     Document Type: Note

References (41)

1. World Health Organization. SARS: How a Global Epidemic Was Stopped. Geneva: World Health Organization; 2006.
2. World Health Organization. Consensus Document on the Epidemiology of Severe Acute Respiratory Syndrome (SARS). Geneva: World Health Organization; 2003. http://www. who.int/csr/sars/en/WHOconsensus.pdf. Accessed March 15, 2011.
3. World Health Organization. Summary table of SARS cases by country, 1 November 2002-7 August 2003. http://www. who.int/csr/sars/country/country2003- 08-15.pdf. Accessed April 8, 2011.
4. Jones KE, Patel NG, Levy MA, et al. Global trends in emerging infectious diseases. Nature 2008;451(7181):990-993. (Pubitemid 351301726)
5. Burke D. Evolvability of emerging viruses. In: Nelson AM, Horsburgh CR, eds. Pathology of Emerging Infections 2. Washington, DC: American Society for Microbiology; 1998:1-12.
6. SARS Expert Committee. SARS in Hong Kong: From Experience to Action. 2003. http://www.sars-expertcom.gov.hk/english/reports/reports/reports-fullrpt. html. Accessed March 15, 2011.
7. Garret L. Social, behavioral, and demographic factors in emerging infections. J Urban Health 1998;75(3):492-500.
8. Mutatkar RK. Public health problems of urbanization. Soc Sci Med 1995;41(7):977-981. (Pubitemid 26432340)
9. The principal agglomerations of the world. City Populations website. http://www.citypopulation.de/world/Agglomerations. html. Accessed March 15, 2011.
10. The largest cities in the world by land area, population and density. City Mayors Statistics website. http://www. citymayors.com/statistics/largest- cities-density-125.html. Accessed March 15, 2011.
11. Yu IT, Xie ZH, Tsoi KK, et al. Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? Clin Infect Dis 2007;44(8):1017-1025. (Pubitemid 46580266)
12. Raboud J, Shigayeva A, McGeer A, et al. Risk factors for SARS transmission from patients requiring intubation: A multicentre investigation in Toronto, Canada. PLoS One 2010;5(5). http://www.plosone.org/article/info:doi/10. 1371/journal.pone.0010717. Accessed April 8, 2011.
13. Fowler RA, Guest CB, Lapinsky SE, et al. Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Am J Respir Crit Care Med 2004; 169(11):1198-1202. (Pubitemid 38680396)
14. Smallpox (fact sheet). World Health Organization website. http://www.who.int/mediacentre/factsheets/smallpox/en/. Accessed March 15, 2011.
15. Henderson DA, Inglesby TV, Bartlett JG, et al; Working Group on Civilian Biodefense. Smallpox as a biological weapon: Medical and public health management. JAMA 1999;281(22):2127-2137. (Pubitemid 29264692)
16. Muyembe-Tamfum JJ, Kipasa M, Kiyungu C, Colebunders R. Ebola outbreak in Kikwit, Democratic Republic of the Congo: Discovery and control measures. J Infect Dis 1999; 179(suppl):S259-S262. (Pubitemid 29091410)
17. Fisher-Hoch SP. Lessons from nosocomial viral haemorrhagic fever outbreaks. Br Med Bull 2005;73-74:123-137. (Pubitemid 43020363)
18. Bell D; World Health Organization Working Group on International and Community Transmission of SARS. Public health interventions and SARS spread, 2003. Emerg Infect Dis 2004 Nov;10(11):1900-1906.
19. Riley S, Fraser C, Donnelly CA, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions. Science 2003;300(5627): 1961-1966. (Pubitemid 36734606)
20. Ho PL, Tang XP, Seto WH. SARS: Hospital infection control and admission strategies. Respirology 2003;8(suppl):S41-S45.
21. World Health Organization. Hospital infection control guidance: care for patients with probable SARS. 2003. http://www.who.int/csr/surveillance/ infectioncontrol/en/. Accessed March 15, 2010.
22. U.S. Centers for Disease Control and Prevention. Public health guidance for community-level preparedness and response to Severe Acute Respiratory Syndrome (SARS). Version 2. Supplement I: Infection control in healthcare, home, and community settings. May 3, 2005. http://www.cdc.gov/ncidod/sars/guidance/i/ pdf/healthcare.pdf. Accessed March 15, 2011.
23. Loeb M, McGeer A, Henry B, et al. SARS among critical care nurses, Toronto. Emerg Infect Dis 2004;4(2):251-255.
24. Greenfeld KT. China Syndrome: The True Story of the 21st Century's First Great Epidemic. New York: HarperCollins; 2006:347.
25. St John RK, King A, de Jong D, Bodie-Collins M, Squires SG, Tam TW. Border screening for SARS. Emerg Infect Dis 2005;11(1):6-10. (Pubitemid 40093345)
26. Hsieh YH, King CC, Chen CW, et al. Quarantine for SARS, Taiwan. Emerg Infect Dis 2005;11(2):278-282. (Pubitemid 40239246)
27. The SARS Commission. Spring of Fear, Volume One. December 2006. http://www.health.gov.on.ca/english/public/pub/ministry-reports/campbell06/ online-rep/index.html. Accessed December 9, 2010.
28. Lipsitch M, Cohen T, Cooper B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003;300:1966-1970. (Pubitemid 36734607)
29. Donnelly CA, Fisher MC, Fraser C, et al. Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect Dis 2004;4(11):672-683. (Pubitemid 39452520)
30. Cross PC, Johnson PL, Lloyd-Smith JO, Getz WM. Utility of R0 as a predictor of disease invasion in structured populations. J R Soc Interface 2007;4(13):315-324. (Pubitemid 46513061)
31. Knobler S. In: Learning from SARS: Preparing for the Next Disease Outbreak. Workshop Summary. Washington, DC: Institute of Medicine (U.S.) Forum on Microbial Threats, Institute of Medicine (U.S.) Board on Global Health. Washington, DC: National Academies Press; 2004.
32. Yu IT, Li Y, Wong TW, et al. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med 2004;350:1731-1739. (Pubitemid 38528700)
33. Li Y, Huang X, Yu IT, Wong TW, Qian H. Role of air distribution in SARS transmission during the largest nosocomial outbreak in Hong Kong. Indoor Air 2005;15(2):83-95. (Pubitemid 40417322)
34. National Advisory Committee on SARS and Public Health. Learning from SARS: Renewal of public health in Canada. Ottawa, Canada: Health Canada; 2003.
35. Fidler DP, Gostin LO. The new International Health Regulations: An historic development for international law and public health. J Law Med Ethics 2006;34(1):85-94, 4. (Pubitemid 43448622)
36. Franco C. Billions for biodefense: federal agency biodefense funding, FY2009-FY2010. Biosecur Bioterror 2009;7(3):291-309.
37. Local health department job losses and program cuts: statelevel tables from January/February 2010. National Association of County and City Health Officials website. March 2010. http://www.naccho.org/advocacy/upload/ JobLossSurvey-State-level-tables-3-10.pdf. Accessed December 9, 2010.
38. Impact of budget cuts on state public health: job and program cuts accelerate, threaten the public's health. Association of State and Territorial Health Officials website. October 2009. http://www.astho.org/Display/ AssetDisplay.aspx?id= 2780. Accessed December 9, 2010.
39. Peiris JSM, Lai ST, Poon LLM, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319-1325. (Pubitemid 36514862)
40. The path of a pandemic. Newsweek May 2, 2009. http://www.newsweek.com/ 2009/05/02/the-path-of-a-pandemic. html. Accessed December 9, 2010.
41. Roberts A, Lamirande EW, Vogel L, et al. Immunogenicity and protective efficacy in mice and hamsters of a b-propiolactone inactivated whole virus SARS-CoV vaccine. Viral Immunol October 2010;23(5):509-519.